As Freenome’s Chief Commercial Officer, Rob is responsible for the company’s commercial strategy and execution, including marketing, sales, client services and market access.

Rob brings more than two decades of experience leading commercial organizations across diagnostics, digital health and healthcare technology. He most recently served as chief commercial officer for Delfi Diagnostics, where he helped shape and deploy the company’s strategic vision to expand market access and deliver its liquid biopsy technology. Prior to Delfi, Rob was chief commercial officer at Invitae. He has also served as chief commercial officer at Ambry Genetics and held leadership roles at Omada Health and Counsyl. Earlier in his career, Rob worked at Quest Diagnostics and AstraZeneca.

Rob holds an MBA with honors from Boston University and a bachelor’s degree in economics from the University of Pittsburgh.